The first Blueprint Medicines trade was made in Q3 2018.
Since then Andreas Halvorsen bought shares five more times and sold shares on six occasions. The investor completely sold their stake between Q3 2020 and Q2 2021.
Avg closing price
Price range
Sold -213 Thousand shares
Q2 2021
Avg closing price
$91.63
Price range
$82.78
-
$101.00
Sold 21.9% shares (-59.6 Thousand shares)
Q1 2021
Avg closing price
$99.84
Price range
$90.71
-
$108.28
Sold 80.9% shares (-1.16 Million shares)
Q4 2020
Avg closing price
$105.38
Price range
$92.08
-
$124.48
Sold 12.2% shares (-199 Thousand shares)
Q3 2020
Avg closing price
$77.01
Price range
$66.45
-
$92.70
Increased shares by 1.8% (+29.2 Thousand shares)
Q2 2020
Avg closing price
$67.64
Price range
$57.09
-
$79.27
Increased shares by 22.5% (+294 Thousand shares)
Q1 2020
Avg closing price
$64.35
Price range
$48.11
-
$82.22
Increased shares by 63.0% (+505 Thousand shares)
Q4 2019
Avg closing price
$74.87
Price range
$66.73
-
$82.59
Increased shares by 45.5% (+251 Thousand shares)
Q3 2019
Avg closing price
$86.44
Price range
$72.90
-
$101.41
Sold 16.3% shares (-108 Thousand shares)
Q2 2019
Avg closing price
$82.54
Price range
$73.54
-
$97.80
Sold 45.1% shares (-542 Thousand shares)
Q1 2019
Avg closing price
$73.89
Price range
$48.70
-
$86.60
Increased shares by 980.4% (+1.09 Million shares)
Q4 2018